xanthohumol has been researched along with Aberrant-Crypt-Foci* in 1 studies
1 other study(ies) available for xanthohumol and Aberrant-Crypt-Foci
Article | Year |
---|---|
Xanthohumol protects against Azoxymethane-induced colorectal cancer in Sprague-Dawley rats.
Colorectal cancer (CRC) is a major health problem and third most common deaths in western world. Dietary interventions together with modified dietary style can prevent the CRC in humans. Xanthohumol (XHA), a polyphenol isolated from Humulus lupulus L. contains many beneficial effects. The aim of the study is to analyze the effect of XHA on Azoxymethane (AOM)-induced experimental CRC in rats. Levels of MDA were increased and enzymic antioxidants levels were decreased in AOM-induced rats. However, these levels were reversed upon XHA treatment. Further, the mRNA expressions of iNOS and COX-2 were also downregulated in XHA treated rats compared to AOM-induced rats. Further, we found that administration of XHA suppressed the wnt/β-catenin signaling together with modulation of apoptotic proteins Bax, Bcl-2, and caspase 3. We conclude that XHA can able to quench the free radicals, inhibits cell proliferation and induces apoptosis, thus it can be a chemopreventive/therapeutic agent against CRC. Topics: Aberrant Crypt Foci; Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Azoxymethane; Cell Proliferation; Colorectal Neoplasms; Flavonoids; Humans; Male; Propiophenones; Rats; Rats, Sprague-Dawley | 2020 |